Delayed and clinically isolated port site carcinosarcoma recurrence as an early indicator of disseminated disease

Monica Dandapani, Brandon Luke L. Seagle, Mary S. Chacho, Shohreh Shahabi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

A 71-year-old woman with suspected endometrial cancer underwent robotic-assisted hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymph node dissection, and infracolic omentectomy revealing a stage II uterine carcinosarcoma with components of serous adenocarcinoma and undifferentiated spindle cell sarcoma. There was no evidence of distant metastasis at the time of surgery. However pelvic washings were positive for malignant cells. She received adjuvant chemotherapy and vaginal cuff brachytherapy. Forty months later she developed a subcutaneous mass at the location of previous port site which was confirmed to be recurrence of the uterine primary. She subsequently developed additional distant metastases to the abdominal wall, lungs, and bone. Port site metastasis (PSM) was the earliest indicator of disseminated metastatic disease in this patient. We review challenges in the management of patients with PSM and propose that PSM be considered as a sign of systemic disease even when presenting as an apparently isolated recurrence.

Original languageEnglish (US)
Pages (from-to)12-15
Number of pages4
JournalGynecologic Oncology Reports
Volume14
DOIs
StatePublished - Nov 1 2015

Keywords

  • Carcinosarcoma recurrence
  • Port site metastasis
  • Uterine carcinosarcoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Delayed and clinically isolated port site carcinosarcoma recurrence as an early indicator of disseminated disease'. Together they form a unique fingerprint.

Cite this